Clinical Trial Update: FOLFIRINOX for 2nd-line Treatment of BTC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating FOLFIRINOX as second-line treatment for biliary tract cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• FOLFIRINOX

Snippet

Sponsor: Dong-A University Hospital | Conditions: Biliary Tract Cancer | Phase 2 | Status: COMPLETED